Tracing molecular margins of lung cancer by internal extractive electrospray ionization mass spectrometry
-
* Corresponding author.
E-mail address: chw8868@gmail.com (H. Chen).
Citation:
Haiyan Lu, Jiayue Ye, Yiping Wei, Hua Zhang, Konstantin Chingin, Vladimir Frankevich, Huanwen Chen. Tracing molecular margins of lung cancer by internal extractive electrospray ionization mass spectrometry[J]. Chinese Chemical Letters,
;2025, 36(2): 110077.
doi:
10.1016/j.cclet.2024.110077
Nitrogen-containing heterocycles are abundant structural motifs in a large number of alkaloids [1], drug molecules [2] and biologically active substances [3]. Although significant accomplishments have been achieved towards the synthesis of various nitrogen heterocyclic compounds in the past few decades [4], modern organic synthesis still demands more efficient and divergent methodologies to access privileged motifs of biological active compounds [5]. As a prime instance, 1, 3-oxazinan-2-ones are not only a core scaffold within natural products [6] and pharmacologically interesting molecules [7], but also widely utilized as key intermediates [8] in the synthesis of drugs [8c, 8f] and bioactive natural products [7b, 8g]. Numerous synthetic approaches were reported to access various substituted 1, 3-oxazinan-2-ones, including halonium-mediated [6c, 9] or metal-catalyzed cyclization [10], intramolecular Michael addition of functionalized homoallylamines/homoallylic alcohols [11], allylic C-H amination [12], and tethered aminohydroxylation of olefins [13]. However, the effective methods to access 6, 6-disubstituted-1, 3-oxazinan-2-one 1, exemplified with the core structural unit of biologically active compounds such as anti-HIV Efavirenz 2 (Merck) [7e] and 11-β-HSD-1 inhibitor 3 [7c], are rare[14] (Fig. 1).
N-Acyliminium ions, acting as important organic synthetic intermediates, are widely used in the formation of C-C and C-heteroatom bonds [15], mostly through intermolecular addition [16] and intramolecular cyclization [17] with various nucleophilic reagents. For examples, the reactions of N-acyliminium ions with olefins could undergo Lewis acid-catalyzed intramolecular addition-cyclization to construct a series of heterocyclic skeletons (Fig. 2, Eq. 1) [18]. Intermolecular reactions of N-acyliminium ions with olefins were also reported [19]. Kobayashi achieved the ring-opening allylation of semicyclic N, O-acetals with allylic silanes (Fig. 2, Eq. 2a) [19a]. Later, Zhang developed the intermolecular coupling reaction of N-acyliminium ions with styrene (Fig. 2, Eq. 2b) [19b]. Notably, N-acyliminium ions could serve as part of electron-deficient dienes, undergoing [4 + 2] cycloaddition with various dienophiles (alkenes or alkynes) [20, 21]. For example, Yoshida established a cycloaddition process of N-acyliminium ions connecting with an alkoxycarbonyl group with alkenes to afford substituted 1, 3-oxazinan-2-one framework, but the formation of corresponding N-acyliminium dienes required anodic oxidation of α-silyl carbamate substrates (Fig. 2, Eq. 3) [20d]. On the basis of our continuous efforts in exploring chemical transformations of semicyclic N, O-acetals [22], we envisioned that such [4 + 2] cycloaddition could lead to various important units. Herein we present an efficient synthetic approach to 4, 6, 6-trisubstituted-1, 3-oxazinan-2-ones6/7/9/10 through TMSOTf-mediated [4 + 2] cycloaddition of semicyclicN, O-acetals 4 with 1, 1-disubstituted ethylenes 5/8 (Fig. 2, Eq. 4).
Our investigation started with the reaction of semicyclic N, O-acetal 4b with 1, 1-diphenylethene 5a. The reaction could not take place in the absence of Lewis acid (Table 1, entry 1). Several types of iron Lewis acids could lead to only faint products (Table 1, entries 2-6). When Ni(OTf)2, Cu(OTf)2 and Sc(OTf)3 were examined, no product was observed (Table 1, entries 7-9). SnCl4 could afford the desired product 7ba in 34% yield (Table 1, entry 10). Slight improvements in yields were achieved when TiCl4 and BF3˙Et2O were applied, and the desired product 7ba could be obtained in moderate yield (48% and 66% respectively, Table 1, entries 11 and 12). Delightfully, TMSOTf could significantly increase the yield of 7ba to 81% (Table 1, entry 13). It was worth noting that the reaction was conducted at -78 ℃. Either increasing or decreasing the loading of TMSOTf resulted in slight drop of the reaction yield (Table 1, entries 14 and 15). The reaction could also afford the desired product using THF and PhMe as solvents, but the corresponding yields were lower compared with that in dichloromethane (Table 1, entries 16 and 17).
With the above identified optimized reaction conditions, the olefin substrates 5b-5j with different electronic properties were examined and the results were summarized in Scheme 1. First, neither hex-1-ene 5b nor cyclohexene 5c could afford any desired product in the presence of TMSOTf. The dienophiles with electron-withdrawing groups, methyl acrylate 5d and (E)-4-phenylbut-3-en-2-one 5e, led to complicated reaction mixtures. Delightfully, styrene 5f and its derivatives (5g and 5h) could generate the desired products 6af, 7bf-7bh in moderate yields and diastereoselectivities. 2-Vinylnaphthalene could also react with 4a and 4b to give the corresponding products 6ai and 7bi in moderate yields and diastereoselectivities. It was worth mentioning that a complex result was obtained when (E)-1, 2-diphenylethene 5j was investigated, probably due to the steric effect during the intermolecular [4 + 2] cycloaddition process.
Next, we turned to investigate the scope and limitation of such addition-cyclization of semicyclic N, O-acetal (4a or 4b) with 1, 1-disubstituted ethylenes 5a, 5k-5v (Scheme 2). When prop-1-en-2-ylbenzene 5k was explored, desired products 6ak, 7bk were obtained in moderate yields and excellent diastereoselectivities. 4-Chloro substitution at phenyl ring (5l) led to slight decrease in yields of 6al, 7bl, but with excellent diastereoselectivities (dr up to 99:1). Replacement of the methyl group of 5k with other alkyl substitutions (5q: n-butyl and 5v: isopropyl) was tolerated, and the desired products 6aq, 7bq, 7bv were afforded in moderate yields under the optimized conditions. Although the n-butyl substituted products 6aq, 7bq showed moderate diastereoselectivities, the isopropyl substituted product 7bv was obtained with excellent diastereoselectivities. In addition, a series of diaryl substituted alkenes were surveyed under the optimized conditions. In general, all these substituted alkenes (5a, 5l-5o) could react with semicyclic N, O-acetals 4a and 4b, affording the desired products 6aa, 6am-6ao, 7ba, 7bm, 7bp in moderate yields. Several benzyl and phenyl olefins 5r-5t were also screened, most of them could give the desired products 6ar-6at, 7br-7bt in excellent yields and diastereoselectivities, except for the p-methoxyphenyl substituted olefin 5r. Substituted olefin 5u containing phenyl and phenethyl could also afford the desired products 6au and 7bu in excellent yields with moderate diastereoselectivities. The methyl and butyl substituted ethylene 5w could also react with N, O-acetal 4b to afford the desired product 7bw in 40% yield, but the diastereoselectivities was lower than those of aryl olefins. The chemical structures of 6aa, 6ak-6au, 7ba, 7bk-7bw were unambiguously confirmed based on the X-ray crystallographic analysis of compound 7bt (see Supporting information for detail).
Next, we turned our attention to investigate the reaction of semicyclic N, O-acetal 4a or 4b with exocyclic olefins 8a-8g, aiming for the formation of 1, 3-oxazinan-2-ones containing a spiro quaternary carbon (Scheme 3). The reaction of 2-methylene-1, 2, 3, 4-tetrahydronaphthalene 8a with semicyclic N, O-acetal 4b afforded the desired product 10ba in 70% yield. The 6-bromo substituted olefin 8b led to 10bb in slightly lower yield of 65%, while the 5-methoxy substituted olefin 8c could generate 10bc in slightly higher yield of 78%. However, the diastereoselectivities of 10ba-10bc were low. The symmetric olefin, 2-methylene-2, 3-dihydro-1H-indene 8d, also worked well with semicyclic N, O-acetals 4a and 4b, affording the desired products 9ad and 10bd in moderate yields. Notably, a simple exocyclic olefin methylenecyclopentane 8g also worked well, and the corresponding product 10bg was obtained in 60% yield. Regarding olefin substrates with the exo-double bond adjacent to the phenyl ring, 5-methylene-6, 7, 8, 9-tetrahydro-5H-benzo[7]annulene 8e bearing a fused seven-membered ring could lead to the corresponding products in higher yields than that of 1-methylene-1, 2, 3, 4-tetrahydronaphthalene 8f bearing a fused six-membered ring. In detail, the desired products 9ae and 10be were obtained in 70% and 63% yields, while the yield of 10bf was only 36%. The diastereoselectivities of 9ae, 10be and 10bf were increased slightly, maybe due to the steric hindrance. The structures of 9ad, 9ae, 10ba-10bg were unambiguously confirmed based on the X-ray crystallographic analysis of compound10bb (see Supporting information for detail).
A possible mechanism for this TMSOTf-mediated [4 + 2] cycloaddition process is presented in Fig. 3 [19a, 20d, 20f]. When semicyclic N, O-acetals 4 reacted with alkenes 5, diene type of N-acyliminium ions Int-1 was first generated under Lewis acid conditions. The subsequent reaction with alkenes 5 gave a six-membered intermediate Int-2, which would define the stereochemical outcome and give Int-3. Upon the cleavage of t-butyl group, the corresponding cycloadducts 6/7/9/10 were produced, along with the release of 2-methylprop-1-ene.
Finally, we focused on the utility of this intermolecular [4 + 2] process of N-acyliminium ions with alkenes in the synthesis of biologically active molecules. Scheme 4 showed a facile synthesis of norallosedamine 12. As a natural product, norallosedamine 12 was isolated from both the Sedum and Lobelia inflata plant family, and have attracted great interest in synthetic chemistry [23]. Starting from the cycloadduct 7bf, Dess-Martin oxidation (DMP) and subsequent reductive amination (Et3SiH/TMSOTf) could produce bicyclic pyrido [1,2-c][1,3]oxazin-1-one 11 in 75% overall yield. Then the ring opening (KOH) of 11 resulted in (±) norallosedamine 12 in 86% yield (dr = 94:6). The spectroscopic and physical data of the synthetic (±)-norallosedamine 12 were identical to the reported data [23a]. Norallosedamine 12 could be potentially converted to other alkaloids of its family by known process [23b, 23d].
In summary, we established a novel and efficient approach for the synthesis of 4, 6-disubstituted- and 4, 6, 6-trisubstituted-1, 3-oxazinan-2-ones 6aa, 6af-6au, 7ba, 7bf-7bw and 6, 6-spiro containing 1, 3-oxazinan-2-ones 9ad, 9ae, 10ba-10bg. The Lewis acid TMSOTf could activate semicyclic N, O-acetals (4a and 4b), and the resulting N-alkoxycarbonyliminium ions readily underwent a [4 + 2] cycloaddition process with 1, 1-disubstituted ethylenes5a, 5k-5w and 8a-8g. The corresponding products were obtained in moderate to excellent yields and diastereoselectivities. In addition, the utility of this methodology was demonstrated by the facile synthesis of natural product (±)-norallosedamine12 from the cycloadduct 7bf.
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
We thank the National Natural Science Foundation of China (No. 21772027 to B.-G. Wei and 21702032 to C.-M. Si) for financial support. The authors also thank Dr. Han-Qing Dong (Arvinas, Inc.) for helpful suggestions.
Supplementary material associated with this article can be found, in the online version, at doi:10.1016/j.cclet.2021.05.003.
H. Sung, J. Ferlay, R.L. Siegel, et al., CA Cancer J. Clin. 71 (2021) 209–249.
doi: 10.3322/caac.21660
P. Goldstraw, K. Chansky, J. Crowley, et al., J. Thorac. Oncol. 11 (2016) 39–51.
J.D. Predina, J. Keating, N. Patel, et al., J. Surg. Oncol. 113 (2016) 264–269.
doi: 10.1002/jso.24130
V. Pirro, R.S. Llor, A.K. Jarmusch, et al., Analyst 142 (2017) 4058–4066.
K. Ashizawa, K. Yoshimura, H. Johno, et al., Oral Oncol. 75 (2017) 111–119.
J.L. Zhang, J. Rector, J.Q. Lin, et al., Sci. Transl. Med. 9 (2017) eaan3968.
J. Xin, S. Han, M. Zheng, et al., Chin. Chem. Lett. 35 (2024) 109165.
H.M. Brown, V. Pirro, R.G. Cooks, Clin. Chem. 64 (2018) 628–630.
doi: 10.1373/clinchem.2017.281923
L.S. Eberlin, R.J. Tibshirani, J. Zhang, et al., Proc. Natl. Acad. Sci. U. S. A. 111 (2014) 2436–2441.
doi: 10.1073/pnas.1400274111
H. Lu, H. Zhang, Y. Wei, et al., Analyst 145 (2020) 313–320.
doi: 10.1039/c9an01365b
L.S. Eberlin, I. Norton, D. Orringer, et al., Proc. Natl. Acad. Sci. U. S. A. 110 (2013) 1611–1616.
doi: 10.1073/pnas.1215687110
V. Pirro, C.M. Alfaro, A.K. Jarmusch, et al., Proc. Natl. Acad. Sci. U. S. A. 114 (2017) 6700–6705.
doi: 10.1073/pnas.1706459114
L. Katz, M. Woolman, F. Talbot, et al., Anal. Chem. 92 (2020) 6349–6357.
doi: 10.1021/acs.analchem.9b05340
J. Balog, L. Sasi-Szabo, J. Kinross, et al., Sci. Transl. Med. 5 (2013) 194ra93.
M.E. King, J. Zhang, J.Q. Lin, et al., Proc. Natl. Acad. Sci. U. S. A. 118 (2021) e2104411118.
P. Saudemont, J. Quanico, Y.M. Robin, et al., Cancer Cell 34 (2018) 840–851.
H. Zhang, K. Chingin, L. Zhu, et al., Anal. Chem. 87 (2015) 2878–2883.
doi: 10.1021/ac504371z
H. Zhang, L. Zhu, L. Luo, et al., J. Agric. Food Chem. 61 (2013) 10691–10698.
doi: 10.1021/jf4032469
H. Zhang, H. Gu, F. Yan, et al., Sci. Rep. 3 (2013) 2495.
J. Xu, S. Xu, Y. Xiao, et al., Anal. Chem. 89 (2017) 11252–11258.
doi: 10.1021/acs.analchem.7b00517
J. Zhang, J. Xu, Y. Ouyang, et al., Sci. Rep. 7 (2017) 3738.
H. Lu, H. Zhang, K. Chingin, et al., Anal. Chem. 91 (2019) 10532–10540.
doi: 10.1021/acs.analchem.9b01507
H. Lu, Y. Li, H. Zhang, et al., Talanta 233 (2021) 122544.
H. Lu, H. Zhang, Y. Xiao, et al., Analyst 145 (2020) 6470–6477.
doi: 10.1039/d0an01080d
H. Zhang, K. Chingin, J. Li, et al., Anal. Chem. 90 (2018) 12101–12107.
doi: 10.1021/acs.analchem.8b03022
H.-Y. Lu, J.-Y. Zhang, W. Zhou, et al., Chin. J. Anal. Chem. 44 (2016) 329–334.
L.C. Lee, C.Y. Liong, A.A. Jemain, Analyst 143 (2018) 3526–3539.
doi: 10.1039/c8an00599k
D. Ruiz-Perez, H. Guan, P. Madhivanan, et al., BMC Bioinf. 21 (2020) 2.
J. Huang, S. Gao, K. Wang, et al., Chin. Chem. Lett. 34 (2023) 107865.
F.G. Almeida, P.F. de Aquino, S.R. Chalub, et al., J. Proteomics 154 (2017) 59–68.
L. Zhang, P. Bu, Trends Cell Biol. 32 (2022) 380–390.
D.P. Patel, G.T. Pauly, T. Tada, et al., J. Pharm. Biomed. Anal. 191 (2020) 113596.
T. Qaradakhi, L.K. Gadanec, K.R. McSweeney, et al., Nutrients 12 (2020) 2847.
doi: 10.3390/nu12092847
Y. Ping, J. Shan, Y. Liu, et al., Cancer Immunol. Immunother. 75 (2022) 1015–1027.
H. Sung, J. Ferlay, R.L. Siegel, et al., CA Cancer J. Clin. 71 (2021) 209–249.
doi: 10.3322/caac.21660
P. Goldstraw, K. Chansky, J. Crowley, et al., J. Thorac. Oncol. 11 (2016) 39–51.
J.D. Predina, J. Keating, N. Patel, et al., J. Surg. Oncol. 113 (2016) 264–269.
doi: 10.1002/jso.24130
V. Pirro, R.S. Llor, A.K. Jarmusch, et al., Analyst 142 (2017) 4058–4066.
K. Ashizawa, K. Yoshimura, H. Johno, et al., Oral Oncol. 75 (2017) 111–119.
J.L. Zhang, J. Rector, J.Q. Lin, et al., Sci. Transl. Med. 9 (2017) eaan3968.
J. Xin, S. Han, M. Zheng, et al., Chin. Chem. Lett. 35 (2024) 109165.
H.M. Brown, V. Pirro, R.G. Cooks, Clin. Chem. 64 (2018) 628–630.
doi: 10.1373/clinchem.2017.281923
L.S. Eberlin, R.J. Tibshirani, J. Zhang, et al., Proc. Natl. Acad. Sci. U. S. A. 111 (2014) 2436–2441.
doi: 10.1073/pnas.1400274111
H. Lu, H. Zhang, Y. Wei, et al., Analyst 145 (2020) 313–320.
doi: 10.1039/c9an01365b
L.S. Eberlin, I. Norton, D. Orringer, et al., Proc. Natl. Acad. Sci. U. S. A. 110 (2013) 1611–1616.
doi: 10.1073/pnas.1215687110
V. Pirro, C.M. Alfaro, A.K. Jarmusch, et al., Proc. Natl. Acad. Sci. U. S. A. 114 (2017) 6700–6705.
doi: 10.1073/pnas.1706459114
L. Katz, M. Woolman, F. Talbot, et al., Anal. Chem. 92 (2020) 6349–6357.
doi: 10.1021/acs.analchem.9b05340
J. Balog, L. Sasi-Szabo, J. Kinross, et al., Sci. Transl. Med. 5 (2013) 194ra93.
M.E. King, J. Zhang, J.Q. Lin, et al., Proc. Natl. Acad. Sci. U. S. A. 118 (2021) e2104411118.
P. Saudemont, J. Quanico, Y.M. Robin, et al., Cancer Cell 34 (2018) 840–851.
H. Zhang, K. Chingin, L. Zhu, et al., Anal. Chem. 87 (2015) 2878–2883.
doi: 10.1021/ac504371z
H. Zhang, L. Zhu, L. Luo, et al., J. Agric. Food Chem. 61 (2013) 10691–10698.
doi: 10.1021/jf4032469
H. Zhang, H. Gu, F. Yan, et al., Sci. Rep. 3 (2013) 2495.
J. Xu, S. Xu, Y. Xiao, et al., Anal. Chem. 89 (2017) 11252–11258.
doi: 10.1021/acs.analchem.7b00517
J. Zhang, J. Xu, Y. Ouyang, et al., Sci. Rep. 7 (2017) 3738.
H. Lu, H. Zhang, K. Chingin, et al., Anal. Chem. 91 (2019) 10532–10540.
doi: 10.1021/acs.analchem.9b01507
H. Lu, Y. Li, H. Zhang, et al., Talanta 233 (2021) 122544.
H. Lu, H. Zhang, Y. Xiao, et al., Analyst 145 (2020) 6470–6477.
doi: 10.1039/d0an01080d
H. Zhang, K. Chingin, J. Li, et al., Anal. Chem. 90 (2018) 12101–12107.
doi: 10.1021/acs.analchem.8b03022
H.-Y. Lu, J.-Y. Zhang, W. Zhou, et al., Chin. J. Anal. Chem. 44 (2016) 329–334.
L.C. Lee, C.Y. Liong, A.A. Jemain, Analyst 143 (2018) 3526–3539.
doi: 10.1039/c8an00599k
D. Ruiz-Perez, H. Guan, P. Madhivanan, et al., BMC Bioinf. 21 (2020) 2.
J. Huang, S. Gao, K. Wang, et al., Chin. Chem. Lett. 34 (2023) 107865.
F.G. Almeida, P.F. de Aquino, S.R. Chalub, et al., J. Proteomics 154 (2017) 59–68.
L. Zhang, P. Bu, Trends Cell Biol. 32 (2022) 380–390.
D.P. Patel, G.T. Pauly, T. Tada, et al., J. Pharm. Biomed. Anal. 191 (2020) 113596.
T. Qaradakhi, L.K. Gadanec, K.R. McSweeney, et al., Nutrients 12 (2020) 2847.
doi: 10.3390/nu12092847
Y. Ping, J. Shan, Y. Liu, et al., Cancer Immunol. Immunother. 75 (2022) 1015–1027.
Lishan Xiong , Xinyuan Li , Xiaojie Lu , Zhendong Zhang , Yan Zhang , Wen Wu , Chenhui Wang . Inhaled multilevel size-tunable, charge-reversible and mucus-traversing composite microspheres as trojan horse: Enhancing lung deposition and tumor penetration. Chinese Chemical Letters, 2024, 35(9): 109384-. doi: 10.1016/j.cclet.2023.109384
Huamei Zhang , Jingjing Liu , Mingyue Li , Shida Ma , Xucong Zhou , Aixia Meng , Weina Han , Jin Zhou . Imaging polarity changes in pneumonia and lung cancer using a lipid droplet-targeted near-infrared fluorescent probe. Chinese Chemical Letters, 2024, 35(12): 110020-. doi: 10.1016/j.cclet.2024.110020
Bohao Liu , Xue Jiang , Ruizhi Ning , Heng Zhao , Yanpeng Zhang , Junnan Zhang , Tianqing Liu , Danyao Qu , Yinhui Bao , Zhanchen Guo , Xiaoyan Zeng , Shan Gao , Kun Fan , Runyi Tao , Jian Ji , Guangjian Zhang , Weiwei Wu . Tedlar bag free: Accurate volatolomics of ⅠA stage non-small cell lung cancer come out in wash. Chinese Chemical Letters, 2025, 36(6): 110301-. doi: 10.1016/j.cclet.2024.110301
Honghao Sun , Huimin Zhao , Ronghui Yin , Chenxi Zhou , Ming Wu , Yueyang Deng , Zhanwei Zhou , Minjie Sun . Injectable hydrogel-based tumor vaccine with fibrotic tumor immune microenvironment remodeling to prevent breast cancer postoperative recurrence and metastases. Chinese Chemical Letters, 2025, 36(5): 110067-. doi: 10.1016/j.cclet.2024.110067
Lu Huang , Jiang Wang , Hong Jiang , Lanfang Chen , Huanwen Chen . On-line determination of selenium compounds in tea infusion by extractive electrospray ionization mass spectrometry combined with a heating reaction device. Chinese Chemical Letters, 2025, 36(1): 109896-. doi: 10.1016/j.cclet.2024.109896
Zhi Li , Shuya Pan , Yuan Tian , Shaowei Liu , Weifeng Wei , Jinlin Wang , Tianfeng Chen , Ling Wang . Selenium nanoparticles enhance the chemotherapeutic efficacy of pemetrexed against non-small cell lung cancer. Chinese Chemical Letters, 2024, 35(12): 110018-. doi: 10.1016/j.cclet.2024.110018
Lingjun Sha , Bing Bo , Jiayu Li , Qi Liu , Ya Cao , Jing Zhao . Precise assessment of lung cancer-derived exosomes based on dual-labelled membrane interface. Chinese Chemical Letters, 2025, 36(4): 110109-. doi: 10.1016/j.cclet.2024.110109
Wenping Dong , Mo Ma , Jingkang Li , Lanlan Xu , Dejiang Gao , Pinyi Ma , Daqian Song . Near-infrared fluorescent probe with large Stokes shift and long emission wavelength for rapid diagnosis of lung cancer via aerosol inhalation delivery. Chinese Chemical Letters, 2025, 36(5): 110147-. doi: 10.1016/j.cclet.2024.110147
Wen Su , Siying Liu , Qingfu Zhang , Zhongyan Zhou , Na Wang , Lei Yue . Temperature-controlled electrospray ionization tandem mass spectrometry study on protein/small molecule interaction. Chinese Chemical Letters, 2025, 36(5): 110237-. doi: 10.1016/j.cclet.2024.110237
Yuanzheng Wang , Chen Zhang , Shuyan Han , Xiaoli Kong , Changyun Quan , Jun Wu , Wei Zhang . Cancer cell membrane camouflaged biomimetic gelatin-based nanogel for tumor inhibition. Chinese Chemical Letters, 2024, 35(11): 109578-. doi: 10.1016/j.cclet.2024.109578
Yanfei Liu , Yaqin Hu , Yifu Tan , Qiwen Chen , Zhenbao Liu . Tumor acidic microenvironment activatable DNA nanostructure for precise cancer cell targeting and inhibition. Chinese Chemical Letters, 2025, 36(1): 110289-. doi: 10.1016/j.cclet.2024.110289
Yanhua Chen , Xian Ding , Jun Zhou , Zhaoying Wang , Yunhai Bo , Ying Hu , Qingce Zang , Jing Xu , Ruiping Zhang , Jiuming He , Fen Yang , Zeper Abliz . Plasma metabolomics combined with mass spectrometry imaging reveals crosstalk between tumor and plasma in gastric cancer genesis and metastasis. Chinese Chemical Letters, 2025, 36(1): 110351-. doi: 10.1016/j.cclet.2024.110351
Shuang Liang , Jianjun Yao , Dan Liu , Mengli Zhou , Yong Cui , Zhaohui Wang . Tumor-responsive covalent organic polymeric nanoparticles enhancing STING activation for cancer immunotherapy. Chinese Chemical Letters, 2025, 36(3): 109856-. doi: 10.1016/j.cclet.2024.109856
Jia-Qi Feng , Xiang Tian , Rui-Ge Cao , Yong-Xiu Li , Wen-Long Liu , Rong Huang , Si-Yong Qin , Ai-Qing Zhang , Yin-Jia Cheng . An AIE-based theranostic nanoplatform for enhanced colorectal cancer therapy: Real-time tumor-tracking and chemical-enhanced photodynamic therapy. Chinese Chemical Letters, 2024, 35(12): 109657-. doi: 10.1016/j.cclet.2024.109657
Yang Feng , Yang-Qing Tian , Yong-Qiang Zhao , Sheng-Jun Chen , Bi-Feng Yuan . Dynamic deformylation of 5-formylcytosine and decarboxylation of 5-carboxylcytosine during differentiation of mouse embryonic stem cells into mouse neurons. Chinese Chemical Letters, 2024, 35(11): 109656-. doi: 10.1016/j.cclet.2024.109656
Zhoupeng Zheng , Shengyi Gong , Qianhua Li , Shiya Zhang , Guoqiang Feng . Lipid droplets and gallbladder targeted fluorescence probe for ratiometric NO imaging in gallstones disease models. Chinese Chemical Letters, 2025, 36(5): 110191-. doi: 10.1016/j.cclet.2024.110191
Qiuye Wang , Yabing Sun , Liangxue Lai , Haijing Cui , Yonglong Ye , Ming Yang , Weihao Zhu , Bo Yuan , Quanliang Mao , Wenzhi Ren , Aiguo Wu . MMP-9-responsive probe for fluorescence-magnetic resonance dual-mode imaging of hepatocellular carcinoma models with different metastatic capacities. Chinese Chemical Letters, 2025, 36(4): 110212-. doi: 10.1016/j.cclet.2024.110212
Xiaoshuai Wu , Bailei Wang , Yichen Li , Xiaoxuan Guan , Mingjing Yin , Wenquan Lv , Yin Chen , Fei Lu , Tao Qin , Huyang Gao , Weiqian Jin , Yifu Huang , Cuiping Li , Ming Gao , Junyu Lu . NIR driven catalytic enhanced acute lung injury therapy by using polydopamine@Co nanozyme via scavenging ROS. Chinese Chemical Letters, 2025, 36(2): 110211-. doi: 10.1016/j.cclet.2024.110211
Dandan Tang , Ningge Xu , Yuyang Fu , Wei Peng , Jinsheng Wu , Heng Liu , Fabiao Yu . Rationally designed an innovative proximity labeling near-infrared fluorogenic probe for imaging of peroxynitrite in acute lung injury. Chinese Chemical Letters, 2025, 36(5): 110082-. doi: 10.1016/j.cclet.2024.110082
Junjie Wang , Yan Wang , Zhengdong Li , Changqiang Xie , Musammir Khan , Xingzhou Peng , Fabiao Yu . Triphenylamine-AIEgens photoactive materials for cancer theranostics. Chinese Chemical Letters, 2024, 35(6): 108934-. doi: 10.1016/j.cclet.2023.108934